ContractAugust 1st, 2019
FiledAugust 1st, 2019CLINICAL TRIAL AGREEMENT SMLOUVA O KLINICKÉM HODNOCENÍ Protocol # 1720304 Protokol číslo 1720304 This Clinical Trial Agreement (“Agreement”) is effective as of the date of its publication in the contract registry (“Effective Date”) by and between Tato smlouva o klinickém hodnocení (dále jen„smlouva“) je účinná dnem jejího uveřejnění v registru smluv (dále jen „datum účinnosti“) mezi Revance Therapeutics Inc, a Delaware corporation with a place of business at 7555 Gateway Boulevard, Newark, California 94560, USA, Tax ID Number: 77-0551645 (“Sponsor”) Revance Therapeutics Inc, Delaware corporation se sídlem 7555 Gateway Boulevard, Newark, California 94560, U.S.A., DIČ: 77-0551645 (dále jen„zadavatel“). Authorized Sponsor´s representative for EU is FGK Representative Service B.V., a limited liability company incorporated under the laws of the Netherlands and having its registered office at Vaartweg 36, (4371 RA), Oudenbosch, the Netherlands as Sponsor’s legal representative in com